Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease

Gastroenterologia y Hepatologia

Volumn 35, Issue 10, 2012, Pages 704-707

  Lozano Herrero, Jesús ^a   Muñoz Bertrán, Eduardo ^a   Ortega González, Isabel ^a   Gómez Espín, Rosa ^a   López Espín, María Isabel ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Copper deficiency; Myelopathy; Wilson's Disease

Indexed keywords

CERULOPLASMIN; CHELATING AGENT; COPPER; COPPER DERIVATIVE; PENICILLAMINE; ZINC DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CLINICAL FEATURE; COPPER DEFICIENCY; COPPER URINE LEVEL; DIET THERAPY; DISEASE COURSE; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; ESOPHAGEAL TRANSECTION; ESOPHAGOGASTRIC DEVASCULARIZATION; ESOPHAGUS SURGERY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; FOOT PARESTHESIA; GAIT DISORDER; GENE MUTATION; HAND PARESTHESIA; HUMAN; HYPERTENSIVE GASTROPATHY; LABORATORY TEST; LIVER CELL; LIVER CIRRHOSIS; LOW COPPER DIET; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PORTOMESENTERIC THROMBOSIS; SPINAL CORD DISEASE; SPLENECTOMY; SPLENORENAL SHUNT; STOMACH DISEASE; THROMBOSIS; URINE LEVEL; WILSON DISEASE;

CERULOPLASMIN; CHELATING AGENTS; CHELATION THERAPY; COPPER; FEMALE; GAIT DISORDERS, NEUROLOGIC; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROLOGIC EXAMINATION; PENICILLAMINE; POLYNEUROPATHIES; REFLEX, ABNORMAL; SENSATION DISORDERS; SPINAL CORD DISEASES; ZINC;

EID: 84870255890     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2012.03.008     Document Type: Article

References (19)

1. Roberts E.A., Schilsky M.L. Diagnosis and treatment of Wilson disease: An update. Hepatology 2008, 47:2089-2111.
2. Ferenci P., Czlonkowska A., Stremmel W., Houwen R., Rosenberg W., Schilsky M. EASL clinical practice guidelines: Wilson's disease. J Hepatol 2012, 56:671-685.
3. Brewer G.J. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2005, 19:185-192.
4. Wiggelinkhuizen M., Tilanus M.E.C., Bollen C.W., Houwen R.H.J. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009, 29:947-958.
5. Linn F.H.H., Houwen R.H.J., van Hattum J., van der Kleij S., van Erpecum K.J. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 2009, 50:1442-1452.
6. Brewer G.J., Yuzbasiyan-Gurkan V., Young A.B. Treatment of Wilson's disease. Semin Neurol 1987, 7:209-220.
7. Danks D.M. Copper deficiency in humans. Annu Rev Nutr 1988, 8:235-257.
8. Halfdanarson T.R., Kumar N., Li C.Y., Phyliky R.L., Hogan W.J. Hematological manifestations of copper deficiency: a retrospective review. Eur J Haematol 2008, 80:523-531.
9. Kumar N., Gross J.B., Ahlskog J.E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004, 63:33-39.
10. Kumar N. Copper Deficiency Myelopathy (Human Swayback). Mayo Clin Proc 2006, 81:1371-1384.
11. Jaiser S.R., Winston G.P. Copper deficiency myelopathy. J Neurol 2010, 257:869-881.
12. Brewer G.J., Yuzbasiyan-Gurkan V., Lee D.Y., Appelman H. Treatment of Wilson's disease with zinc VI. Initial treatment studies. J Lab Clin Med 1989, 114:633-638.
13. Halfdanarson T.R., Kumar N., Hogan W.J., Murray J.A. Copper deficiency in celiac disease. J Clin Gastroenterol 2009, 43:162-164.
14. Nations S.P., Boyer P.J., Love L.A., Burritt M.F., Butz J.A., Wolfe G.I., Hynan L.S., Reisch J., Trivedi J.R. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 2008, 71:639-643.
15. Czlonkowska A., Gajda J., Rodo M. Effects of long-term treatment in Wilson's disease with penicillamine. J Neurol 1996, 243:269-273.
16. Horvath J., Beris P., Giostra E., Martin P.Y., Burkhard P.R. Zinc-induced copper deficiency in Wilson disease. J Neurol Neurosur Psychiatry 2010, 81:1410-1411.
17. Foubert-Samier A., Kazadi A., Rouanet M., Vital A., Lagueny A., Tison F., Meissner W. Axonal sensory motor neuropathy in copper-deficient Wilson's disease. Muscle Nerve 2009, 40:294-296.
18. Benbir G., Gunduz A., Ertan S., Ozkara C. Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease. Seizure 2010, 19:602-604.
19. Narayan S.K., Kaveer N. CNS demyelination due to hypocupremia in Wilson's disease from overzealous treatment. Neurol India 2006, 54:110-111.